The U.S. Food and Drug Administration has approved the HeartWare Ventricular Assist System.

The FDA said that the approval of the device was granted based on the results of a clinical study of 137 advanced heart failure patients.
The release added that the HeartWare device can be implanted as a single unit near the heart, but cautioned that the possibility of serious adverse reactions need to be taken into consideration before opting for this therapy.
Source-Medindia